Clinical Trial Update: Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant chemotherapy plus retifanlimab in patients with resectable soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Retifanlimab (retifanlimab)

Snippet

Sponsor: Institut Bergonié | Conditions: Resectable Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING